0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Absorbable Hemostatic Gelatin Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-2L17537
Home | Market Reports | Health| Medical Devices & Equipment
Global Absorbable Hemostatic Gelatin Market Research Report 2024
BUY CHAPTERS

Global Absorbable Hemostatic Gelatin Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-2L17537
Report
October 2025
Pages:170
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Absorbable Hemostatic Gelatin Market

The global Absorbable Hemostatic Gelatin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Absorbable Hemostatic Gelatin leading manufacturers including Baxter, Johnson & Johnson, Cura Medical, Pfizer, Ferrosan Medical Devices, B.Braun, Curasan AG, Meril Life Sciences, Aegis Lifesciences, Shenzhen HUANOVA, etc., dominate supply; the top five capture approximately % of global revenue, with Baxter leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Absorbable Hemostatic Gelatin market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Absorbable Hemostatic Gelatin Market Report

Report Metric Details
Report Name Absorbable Hemostatic Gelatin Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Baxter, Johnson & Johnson, Cura Medical, Pfizer, Ferrosan Medical Devices, B.Braun, Curasan AG, Meril Life Sciences, Aegis Lifesciences, Shenzhen HUANOVA, Jiangxi Boenrui, Beijing Nashi Biosurgery
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Absorbable Hemostatic Gelatin study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Absorbable Hemostatic Gelatin Market report?

Ans: The main players in the Absorbable Hemostatic Gelatin Market are Baxter, Johnson & Johnson, Cura Medical, Pfizer, Ferrosan Medical Devices, B.Braun, Curasan AG, Meril Life Sciences, Aegis Lifesciences, Shenzhen HUANOVA, Jiangxi Boenrui, Beijing Nashi Biosurgery

What are the Application segmentation covered in the Absorbable Hemostatic Gelatin Market report?

Ans: The Applications covered in the Absorbable Hemostatic Gelatin Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Absorbable Hemostatic Gelatin Market report?

Ans: The Types covered in the Absorbable Hemostatic Gelatin Market report are Gelatin Sponge, Gelatin Powder, Gelatin Matrix

Recommended Reports

Hemostatic Materials

Gelatin Products

Hemostatic Sponges

1 Study Coverage
1.1 Introduction to Absorbable Hemostatic Gelatin: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Absorbable Hemostatic Gelatin Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Gelatin Sponge
1.2.3 Gelatin Powder
1.2.4 Gelatin Matrix
1.3 Market Segmentation by Application
1.3.1 Global Absorbable Hemostatic Gelatin Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Absorbable Hemostatic Gelatin Revenue Estimates and Forecasts 2020-2031
2.2 Global Absorbable Hemostatic Gelatin Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Absorbable Hemostatic Gelatin Sales Estimates and Forecasts 2020-2031
2.4 Global Absorbable Hemostatic Gelatin Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Absorbable Hemostatic Gelatin Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Absorbable Hemostatic Gelatin Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Gelatin Sponge Market Size by Manufacturers
3.5.2 Gelatin Powder Market Size by Manufacturers
3.5.3 Gelatin Matrix Market Size by Manufacturers
3.6 Global Absorbable Hemostatic Gelatin Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Absorbable Hemostatic Gelatin Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Absorbable Hemostatic Gelatin Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Absorbable Hemostatic Gelatin Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Absorbable Hemostatic Gelatin Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Absorbable Hemostatic Gelatin Sales and Revenue by Type (2020-2031)
6.4 North America Absorbable Hemostatic Gelatin Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Absorbable Hemostatic Gelatin Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Absorbable Hemostatic Gelatin Sales and Revenue by Type (2020-2031)
7.4 Europe Absorbable Hemostatic Gelatin Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Absorbable Hemostatic Gelatin Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Absorbable Hemostatic Gelatin Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Absorbable Hemostatic Gelatin Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Absorbable Hemostatic Gelatin Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Absorbable Hemostatic Gelatin Sales and Revenue by Type (2020-2031)
9.4 Central and South America Absorbable Hemostatic Gelatin Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Absorbable Hemostatic Gelatin Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Absorbable Hemostatic Gelatin Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Absorbable Hemostatic Gelatin Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Absorbable Hemostatic Gelatin Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Business Overview
11.1.3 Baxter Absorbable Hemostatic Gelatin Product Models, Descriptions and Specifications
11.1.4 Baxter Absorbable Hemostatic Gelatin Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Baxter Absorbable Hemostatic Gelatin Sales by Product in 2024
11.1.6 Baxter Absorbable Hemostatic Gelatin Sales by Application in 2024
11.1.7 Baxter Absorbable Hemostatic Gelatin Sales by Geographic Area in 2024
11.1.8 Baxter Absorbable Hemostatic Gelatin SWOT Analysis
11.1.9 Baxter Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Corporation Information
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Absorbable Hemostatic Gelatin Product Models, Descriptions and Specifications
11.2.4 Johnson & Johnson Absorbable Hemostatic Gelatin Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Johnson & Johnson Absorbable Hemostatic Gelatin Sales by Product in 2024
11.2.6 Johnson & Johnson Absorbable Hemostatic Gelatin Sales by Application in 2024
11.2.7 Johnson & Johnson Absorbable Hemostatic Gelatin Sales by Geographic Area in 2024
11.2.8 Johnson & Johnson Absorbable Hemostatic Gelatin SWOT Analysis
11.2.9 Johnson & Johnson Recent Developments
11.3 Cura Medical
11.3.1 Cura Medical Corporation Information
11.3.2 Cura Medical Business Overview
11.3.3 Cura Medical Absorbable Hemostatic Gelatin Product Models, Descriptions and Specifications
11.3.4 Cura Medical Absorbable Hemostatic Gelatin Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Cura Medical Absorbable Hemostatic Gelatin Sales by Product in 2024
11.3.6 Cura Medical Absorbable Hemostatic Gelatin Sales by Application in 2024
11.3.7 Cura Medical Absorbable Hemostatic Gelatin Sales by Geographic Area in 2024
11.3.8 Cura Medical Absorbable Hemostatic Gelatin SWOT Analysis
11.3.9 Cura Medical Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Absorbable Hemostatic Gelatin Product Models, Descriptions and Specifications
11.4.4 Pfizer Absorbable Hemostatic Gelatin Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Pfizer Absorbable Hemostatic Gelatin Sales by Product in 2024
11.4.6 Pfizer Absorbable Hemostatic Gelatin Sales by Application in 2024
11.4.7 Pfizer Absorbable Hemostatic Gelatin Sales by Geographic Area in 2024
11.4.8 Pfizer Absorbable Hemostatic Gelatin SWOT Analysis
11.4.9 Pfizer Recent Developments
11.5 Ferrosan Medical Devices
11.5.1 Ferrosan Medical Devices Corporation Information
11.5.2 Ferrosan Medical Devices Business Overview
11.5.3 Ferrosan Medical Devices Absorbable Hemostatic Gelatin Product Models, Descriptions and Specifications
11.5.4 Ferrosan Medical Devices Absorbable Hemostatic Gelatin Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Ferrosan Medical Devices Absorbable Hemostatic Gelatin Sales by Product in 2024
11.5.6 Ferrosan Medical Devices Absorbable Hemostatic Gelatin Sales by Application in 2024
11.5.7 Ferrosan Medical Devices Absorbable Hemostatic Gelatin Sales by Geographic Area in 2024
11.5.8 Ferrosan Medical Devices Absorbable Hemostatic Gelatin SWOT Analysis
11.5.9 Ferrosan Medical Devices Recent Developments
11.6 B.Braun
11.6.1 B.Braun Corporation Information
11.6.2 B.Braun Business Overview
11.6.3 B.Braun Absorbable Hemostatic Gelatin Product Models, Descriptions and Specifications
11.6.4 B.Braun Absorbable Hemostatic Gelatin Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 B.Braun Recent Developments
11.7 Curasan AG
11.7.1 Curasan AG Corporation Information
11.7.2 Curasan AG Business Overview
11.7.3 Curasan AG Absorbable Hemostatic Gelatin Product Models, Descriptions and Specifications
11.7.4 Curasan AG Absorbable Hemostatic Gelatin Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Curasan AG Recent Developments
11.8 Meril Life Sciences
11.8.1 Meril Life Sciences Corporation Information
11.8.2 Meril Life Sciences Business Overview
11.8.3 Meril Life Sciences Absorbable Hemostatic Gelatin Product Models, Descriptions and Specifications
11.8.4 Meril Life Sciences Absorbable Hemostatic Gelatin Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Meril Life Sciences Recent Developments
11.9 Aegis Lifesciences
11.9.1 Aegis Lifesciences Corporation Information
11.9.2 Aegis Lifesciences Business Overview
11.9.3 Aegis Lifesciences Absorbable Hemostatic Gelatin Product Models, Descriptions and Specifications
11.9.4 Aegis Lifesciences Absorbable Hemostatic Gelatin Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Aegis Lifesciences Recent Developments
11.10 Shenzhen HUANOVA
11.10.1 Shenzhen HUANOVA Corporation Information
11.10.2 Shenzhen HUANOVA Business Overview
11.10.3 Shenzhen HUANOVA Absorbable Hemostatic Gelatin Product Models, Descriptions and Specifications
11.10.4 Shenzhen HUANOVA Absorbable Hemostatic Gelatin Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Shenzhen HUANOVA Recent Developments
11.11 Jiangxi Boenrui
11.11.1 Jiangxi Boenrui Corporation Information
11.11.2 Jiangxi Boenrui Business Overview
11.11.3 Jiangxi Boenrui Absorbable Hemostatic Gelatin Product Models, Descriptions and Specifications
11.11.4 Jiangxi Boenrui Absorbable Hemostatic Gelatin Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Jiangxi Boenrui Recent Developments
11.12 Beijing Nashi Biosurgery
11.12.1 Beijing Nashi Biosurgery Corporation Information
11.12.2 Beijing Nashi Biosurgery Business Overview
11.12.3 Beijing Nashi Biosurgery Absorbable Hemostatic Gelatin Product Models, Descriptions and Specifications
11.12.4 Beijing Nashi Biosurgery Absorbable Hemostatic Gelatin Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Beijing Nashi Biosurgery Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Absorbable Hemostatic Gelatin Industry Chain
12.2 Absorbable Hemostatic Gelatin Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Absorbable Hemostatic Gelatin Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Absorbable Hemostatic Gelatin Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Absorbable Hemostatic Gelatin Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Absorbable Hemostatic Gelatin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Absorbable Hemostatic Gelatin Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Absorbable Hemostatic Gelatin Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Absorbable Hemostatic Gelatin Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Absorbable Hemostatic Gelatin Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Absorbable Hemostatic Gelatin Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Absorbable Hemostatic Gelatin Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Absorbable Hemostatic Gelatin Sales by Region (2020-2025) & (K Units)
 Table 8. Global Absorbable Hemostatic Gelatin Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Absorbable Hemostatic Gelatin Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Absorbable Hemostatic Gelatin Sales Share by Manufacturers (2020-2025)
 Table 12. Global Absorbable Hemostatic Gelatin Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Absorbable Hemostatic Gelatin Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Absorbable Hemostatic Gelatin by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Absorbable Hemostatic Gelatin as of 2024)
 Table 16. Global Absorbable Hemostatic Gelatin Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Absorbable Hemostatic Gelatin Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Absorbable Hemostatic Gelatin Manufacturing Base and Headquarters
 Table 19. Global Absorbable Hemostatic Gelatin Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Absorbable Hemostatic Gelatin Sales by Type (2020-2025) & (K Units)
 Table 23. Global Absorbable Hemostatic Gelatin Sales by Type (2026-2031) & (K Units)
 Table 24. Global Absorbable Hemostatic Gelatin Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Absorbable Hemostatic Gelatin Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Absorbable Hemostatic Gelatin ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Absorbable Hemostatic Gelatin Sales by Application (2020-2025) & (K Units)
 Table 29. Global Absorbable Hemostatic Gelatin Sales by Application (2026-2031) & (K Units)
 Table 30. Absorbable Hemostatic Gelatin High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Absorbable Hemostatic Gelatin Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Absorbable Hemostatic Gelatin Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Absorbable Hemostatic Gelatin ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Absorbable Hemostatic Gelatin Growth Accelerators and Market Barriers
 Table 37. North America Absorbable Hemostatic Gelatin Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Absorbable Hemostatic Gelatin Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Absorbable Hemostatic Gelatin Growth Accelerators and Market Barriers
 Table 40. Europe Absorbable Hemostatic Gelatin Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Absorbable Hemostatic Gelatin Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Absorbable Hemostatic Gelatin Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Absorbable Hemostatic Gelatin Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Absorbable Hemostatic Gelatin Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Absorbable Hemostatic Gelatin Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Absorbable Hemostatic Gelatin Investment Opportunities and Key Challenges
 Table 47. Central and South America Absorbable Hemostatic Gelatin Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Absorbable Hemostatic Gelatin Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Absorbable Hemostatic Gelatin Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Baxter Corporation Information
 Table 51. Baxter Description and Major Businesses
 Table 52. Baxter Product Models, Descriptions and Specifications
 Table 53. Baxter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Baxter Sales Value Proportion by Product in 2024
 Table 55. Baxter Sales Value Proportion by Application in 2024
 Table 56. Baxter Sales Value Proportion by Geographic Area in 2024
 Table 57. Baxter Absorbable Hemostatic Gelatin SWOT Analysis
 Table 58. Baxter Recent Developments
 Table 59. Johnson & Johnson Corporation Information
 Table 60. Johnson & Johnson Description and Major Businesses
 Table 61. Johnson & Johnson Product Models, Descriptions and Specifications
 Table 62. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Johnson & Johnson Sales Value Proportion by Product in 2024
 Table 64. Johnson & Johnson Sales Value Proportion by Application in 2024
 Table 65. Johnson & Johnson Sales Value Proportion by Geographic Area in 2024
 Table 66. Johnson & Johnson Absorbable Hemostatic Gelatin SWOT Analysis
 Table 67. Johnson & Johnson Recent Developments
 Table 68. Cura Medical Corporation Information
 Table 69. Cura Medical Description and Major Businesses
 Table 70. Cura Medical Product Models, Descriptions and Specifications
 Table 71. Cura Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Cura Medical Sales Value Proportion by Product in 2024
 Table 73. Cura Medical Sales Value Proportion by Application in 2024
 Table 74. Cura Medical Sales Value Proportion by Geographic Area in 2024
 Table 75. Cura Medical Absorbable Hemostatic Gelatin SWOT Analysis
 Table 76. Cura Medical Recent Developments
 Table 77. Pfizer Corporation Information
 Table 78. Pfizer Description and Major Businesses
 Table 79. Pfizer Product Models, Descriptions and Specifications
 Table 80. Pfizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Pfizer Sales Value Proportion by Product in 2024
 Table 82. Pfizer Sales Value Proportion by Application in 2024
 Table 83. Pfizer Sales Value Proportion by Geographic Area in 2024
 Table 84. Pfizer Absorbable Hemostatic Gelatin SWOT Analysis
 Table 85. Pfizer Recent Developments
 Table 86. Ferrosan Medical Devices Corporation Information
 Table 87. Ferrosan Medical Devices Description and Major Businesses
 Table 88. Ferrosan Medical Devices Product Models, Descriptions and Specifications
 Table 89. Ferrosan Medical Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Ferrosan Medical Devices Sales Value Proportion by Product in 2024
 Table 91. Ferrosan Medical Devices Sales Value Proportion by Application in 2024
 Table 92. Ferrosan Medical Devices Sales Value Proportion by Geographic Area in 2024
 Table 93. Ferrosan Medical Devices Absorbable Hemostatic Gelatin SWOT Analysis
 Table 94. Ferrosan Medical Devices Recent Developments
 Table 95. B.Braun Corporation Information
 Table 96. B.Braun Description and Major Businesses
 Table 97. B.Braun Product Models, Descriptions and Specifications
 Table 98. B.Braun Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. B.Braun Recent Developments
 Table 100. Curasan AG Corporation Information
 Table 101. Curasan AG Description and Major Businesses
 Table 102. Curasan AG Product Models, Descriptions and Specifications
 Table 103. Curasan AG Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Curasan AG Recent Developments
 Table 105. Meril Life Sciences Corporation Information
 Table 106. Meril Life Sciences Description and Major Businesses
 Table 107. Meril Life Sciences Product Models, Descriptions and Specifications
 Table 108. Meril Life Sciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Meril Life Sciences Recent Developments
 Table 110. Aegis Lifesciences Corporation Information
 Table 111. Aegis Lifesciences Description and Major Businesses
 Table 112. Aegis Lifesciences Product Models, Descriptions and Specifications
 Table 113. Aegis Lifesciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Aegis Lifesciences Recent Developments
 Table 115. Shenzhen HUANOVA Corporation Information
 Table 116. Shenzhen HUANOVA Description and Major Businesses
 Table 117. Shenzhen HUANOVA Product Models, Descriptions and Specifications
 Table 118. Shenzhen HUANOVA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Shenzhen HUANOVA Recent Developments
 Table 120. Jiangxi Boenrui Corporation Information
 Table 121. Jiangxi Boenrui Description and Major Businesses
 Table 122. Jiangxi Boenrui Product Models, Descriptions and Specifications
 Table 123. Jiangxi Boenrui Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Jiangxi Boenrui Recent Developments
 Table 125. Beijing Nashi Biosurgery Corporation Information
 Table 126. Beijing Nashi Biosurgery Description and Major Businesses
 Table 127. Beijing Nashi Biosurgery Product Models, Descriptions and Specifications
 Table 128. Beijing Nashi Biosurgery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. Beijing Nashi Biosurgery Recent Developments
 Table 130. Key Raw Materials Distribution
 Table 131. Raw Materials Key Suppliers
 Table 132. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 133. Milestones in Production Technology Evolution
 Table 134. Distributors List
 Table 135. Market Trends and Market Evolution
 Table 136. Market Drivers and Opportunities
 Table 137. Market Challenges, Risks, and Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources


List of Figures
 Figure 1. Absorbable Hemostatic Gelatin Product Picture
 Figure 2. Global Absorbable Hemostatic Gelatin Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Gelatin Sponge Product Picture
 Figure 4. Gelatin Powder Product Picture
 Figure 5. Gelatin Matrix Product Picture
 Figure 6. Global Absorbable Hemostatic Gelatin Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Hospital
 Figure 8. Clinic
 Figure 9. Others
 Figure 10. Absorbable Hemostatic Gelatin Report Years Considered
 Figure 11. Global Absorbable Hemostatic Gelatin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Absorbable Hemostatic Gelatin Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Absorbable Hemostatic Gelatin Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Absorbable Hemostatic Gelatin Revenue Market Share by Region (2020-2031)
 Figure 15. Global Absorbable Hemostatic Gelatin Sales (2020-2031) & (K Units)
 Figure 16. Global Absorbable Hemostatic Gelatin Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 17. Global Absorbable Hemostatic Gelatin Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Absorbable Hemostatic Gelatin Sales Volume Market Share in 2024
 Figure 19. Global Absorbable Hemostatic Gelatin Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. Gelatin Sponge Revenue Market Share by Manufacturer in 2024
 Figure 22. Gelatin Powder Revenue Market Share by Manufacturer in 2024
 Figure 23. Gelatin Matrix Revenue Market Share by Manufacturer in 2024
 Figure 24. Global Absorbable Hemostatic Gelatin Sales Market Share by Type (2020-2031)
 Figure 25. Global Absorbable Hemostatic Gelatin Revenue Market Share by Type (2020-2031)
 Figure 26. Global Absorbable Hemostatic Gelatin Sales Market Share by Application (2020-2031)
 Figure 27. Global Absorbable Hemostatic Gelatin Revenue Market Share by Application (2020-2031)
 Figure 28. North America Absorbable Hemostatic Gelatin Sales YoY (2020-2031) & (K Units)
 Figure 29. North America Absorbable Hemostatic Gelatin Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. North America Top 5 Manufacturers Absorbable Hemostatic Gelatin Sales Revenue (US$ Million) in 2024
 Figure 31. North America Absorbable Hemostatic Gelatin Sales Volume (K Units) by Type (2020- 2031)
 Figure 32. North America Absorbable Hemostatic Gelatin Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 33. North America Absorbable Hemostatic Gelatin Sales Volume (K Units) by Application (2020-2031)
 Figure 34. North America Absorbable Hemostatic Gelatin Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 35. US Absorbable Hemostatic Gelatin Revenue (2020-2031) & (US$ Million)
 Figure 36. Canada Absorbable Hemostatic Gelatin Revenue (2020-2031) & (US$ Million)
 Figure 37. Mexico Absorbable Hemostatic Gelatin Revenue (2020-2031) & (US$ Million)
 Figure 38. Europe Absorbable Hemostatic Gelatin Sales YoY (2020-2031) & (K Units)
 Figure 39. Europe Absorbable Hemostatic Gelatin Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Europe Top 5 Manufacturers Absorbable Hemostatic Gelatin Sales Revenue (US$ Million) in 2024
 Figure 41. Europe Absorbable Hemostatic Gelatin Sales Volume (K Units) by Type (2020-2031)
 Figure 42. Europe Absorbable Hemostatic Gelatin Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Europe Absorbable Hemostatic Gelatin Sales Volume (K Units) by Application (2020-2031)
 Figure 44. Europe Absorbable Hemostatic Gelatin Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 45. Germany Absorbable Hemostatic Gelatin Revenue (2020-2031) & (US$ Million)
 Figure 46. France Absorbable Hemostatic Gelatin Revenue (2020-2031) & (US$ Million)
 Figure 47. U.K. Absorbable Hemostatic Gelatin Revenue (2020-2031) & (US$ Million)
 Figure 48. Italy Absorbable Hemostatic Gelatin Revenue (2020-2031) & (US$ Million)
 Figure 49. Russia Absorbable Hemostatic Gelatin Revenue (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Absorbable Hemostatic Gelatin Sales YoY (2020-2031) & (K Units)
 Figure 51. Asia-Pacific Absorbable Hemostatic Gelatin Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Top 8 Manufacturers Absorbable Hemostatic Gelatin Sales Revenue (US$ Million) in 2024
 Figure 53. Asia-Pacific Absorbable Hemostatic Gelatin Sales Volume (K Units) by Type (2020- 2031)
 Figure 54. Asia-Pacific Absorbable Hemostatic Gelatin Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 55. Asia-Pacific Absorbable Hemostatic Gelatin Sales Volume (K Units) by Application (2020-2031)
 Figure 56. Asia-Pacific Absorbable Hemostatic Gelatin Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Indonesia Absorbable Hemostatic Gelatin Revenue (2020-2031) & (US$ Million)
 Figure 58. Japan Absorbable Hemostatic Gelatin Revenue (2020-2031) & (US$ Million)
 Figure 59. South Korea Absorbable Hemostatic Gelatin Revenue (2020-2031) & (US$ Million)
 Figure 60. China Taiwan Absorbable Hemostatic Gelatin Revenue (2020-2031) & (US$ Million)
 Figure 61. India Absorbable Hemostatic Gelatin Revenue (2020-2031) & (US$ Million)
 Figure 62. Central and South America Absorbable Hemostatic Gelatin Sales YoY (2020-2031) & (K Units)
 Figure 63. Central and South America Absorbable Hemostatic Gelatin Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Central and South America Top 5 Manufacturers Absorbable Hemostatic Gelatin Sales Revenue (US$ Million) in 2024
 Figure 65. Central and South America Absorbable Hemostatic Gelatin Sales Volume (K Units) by Type (2021-2031)
 Figure 66. Central and South America Absorbable Hemostatic Gelatin Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 67. Central and South America Absorbable Hemostatic Gelatin Sales Volume (K Units) by Application (2020-2031)
 Figure 68. Central and South America Absorbable Hemostatic Gelatin Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Brazil Absorbable Hemostatic Gelatin Revenue (2020-2025) & (US$ Million)
 Figure 70. Argentina Absorbable Hemostatic Gelatin Revenue (2020-2025) & (US$ Million)
 Figure 71. Middle East, and Africa Absorbable Hemostatic Gelatin Sales YoY (2020-2031) & (K Units)
 Figure 72. Middle East and Africa Absorbable Hemostatic Gelatin Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Middle East and Africa Top 5 Manufacturers Absorbable Hemostatic Gelatin Sales Revenue (US$ Million) in 2024
 Figure 74. Middle East and Africa Absorbable Hemostatic Gelatin Sales Volume (K Units) by Type (2021-2031)
 Figure 75. South America Absorbable Hemostatic Gelatin Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Middle East and Africa Absorbable Hemostatic Gelatin Sales Volume (K Units) by Application (2020-2031)
 Figure 77. Middle East and Africa Absorbable Hemostatic Gelatin Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. GCC Countries Absorbable Hemostatic Gelatin Revenue (2020-2025) & (US$ Million)
 Figure 79. Turkey Absorbable Hemostatic Gelatin Revenue (2020-2025) & (US$ Million)
 Figure 80. Egypt Absorbable Hemostatic Gelatin Revenue (2020-2025) & (US$ Million)
 Figure 81. South Africa Absorbable Hemostatic Gelatin Revenue (2020-2025) & (US$ Million)
 Figure 82. Absorbable Hemostatic Gelatin Industry Chain Mapping
 Figure 83. Regional Absorbable Hemostatic Gelatin Manufacturing Base Distribution (%)
 Figure 84. Global Absorbable Hemostatic Gelatin Production Market Share by Region (2020-2031)
 Figure 85. Absorbable Hemostatic Gelatin Production Process
 Figure 86. Regional Absorbable Hemostatic Gelatin Production Cost Structure
 Figure 87. Channels of Distribution (Direct Vs Distribution)
 Figure 88. Bottom-up and Top-down Approaches for This Report
 Figure 89. Data Triangulation
 Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37F12574
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15J20209
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8O12834
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adult Nasogastric Feeding Tube Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36J12622
Wed Dec 03 00:00:00 UTC 2025

Add to Cart